Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Stefanie, Sawall"'
Autor:
Thomas, Walle, Sunanjay, Bajaj, Joscha A, Kraske, Thomas, Rösner, Christiane S, Cussigh, Katharina A, Kälber, Lisa Jasmin, Müller, Sophia Boyoung, Strobel, Jana, Burghaus, Stefan M, Kallenberger, Christoph K, Stein-Thöringer, Maximilian, Jenzer, Antonia, Schubert, Steffen, Kahle, Anja, Williams, Birgit, Hoyler, Lin, Zielske, Renate, Skatula, Stefanie, Sawall, Mathias F, Leber, Russell Z, Kunes, Johannes, Krisam, Carlo, Fremd, Andreas, Schneeweiss, Jürgen, Krauss, Leonidas, Apostolidis, Anne Katrin, Berger, Georg M, Haag, Stefanie, Zschäbitz, Niels, Halama, Christoph, Springfeld, Romy, Kirsten, Jessica C, Hassel, Dirk, Jäger
Publikováno v:
Nature cancer. 3(9)
Patients with cancer frequently receive immune-checkpoint inhibitors (ICIs), which may modulate immune responses to COVID-19 vaccines. Recently, cytokine release syndrome (CRS) was observed in a patient with cancer who received BTN162b2 vaccination u
Autor:
Melanie Janning, Boris Fehse, Stefanie Sawall, Mark Wroblewski, Denis M. Schewe, Niels Weinhold, Isabel Ben-Batalla, Djordje Atanackovic, Victoria Gensch, H. Taipaleenmaeki, Eric Hesse, Bernard Klein, Walter Fiedler, Manfred Binder, Miguel Cubas-Cordova, N Kröger, Sonja Loges, Dirk Hose, Klaus Pantel, Marc-Steffen Raab, Anja Seckinger, Tobias Meissner, Carsten Bokemeyer, Kristoffer Riecken, Jonas S. Waizenegger
Publikováno v:
Leukemia
Leukemia, Nature Publishing Group: Open Access Hybrid Model Option B, 2020, 34 (9), pp.2542-2542. ⟨10.1038/s41375-020-0781-5⟩
Leukemia, Nature Publishing Group: Open Access Hybrid Model Option B, 2020, 34 (9), pp.2542-2542. ⟨10.1038/s41375-020-0781-5⟩
International audience; An amendment to this paper has been published and can be accessed via a link at the top of the paper.
Autor:
Melanie Janning, Mark Wroblewski, Stefanie Sawall, Lin Zhao, Victoria Gensch, Boris Fehse, Miguel Cubas-Cordova, Kristoffer Riecken, Isabel Ben-Batalla, Florian Udonta, Klaus Pantel, Sonja Loges, Inigo Martinez-Zubiaurre, Jonas S. Waizenegger, Carsten Bokemeyer
Publikováno v:
Europe PubMed Central
Oncotarget
Scopus-Elsevier
Oncotarget
Scopus-Elsevier
// Isabel Ben-Batalla 1,2 , Miguel Cubas-Cordova 1,2 , Florian Udonta 1,2 , Mark Wroblewski 1,2 , Jonas S. Waizenegger 1,2 , Melanie Janning 1,2 , Stefanie Sawall 1,2 , Victoria Gensch 1,2 , Lin Zhao 1,2 , Inigo Martinez-Zubiaurre 3 , Kristoffer Riec
Autor:
Christian Grossardt, A Temme, Guy Ungerechts, C von Kalle, E P Rieber, Sascha Bossow, Roberto Cattaneo, Stefanie Sawall, Mathias F. Leber
Publikováno v:
Cancer Gene Therapy. 18:598-608
No curative therapy is currently available for locally advanced or metastatic pancreatic cancer. Therefore, new therapeutic approaches must be considered. Measles virus (MV) vaccine strains have shown promising oncolytic activity against a variety of
Autor:
Denis M. Schewe, Miguel Cubas-Cordova, Melanie Janning, N Kröger, Mark Wroblewski, Tobias Meissner, Eric Hesse, H. Taipaleenmaeki, Jonas S. Waizenegger, Kristoffer Riecken, Walter Fiedler, Bernard Klein, Manfred Binder, Isabel Ben-Batalla, Niels Weinhold, Djordje Atanackovic, Stefanie Sawall, Sonja Loges, Victoria Gensch, Boris Fehse, Anja Seckinger, Klaus Pantel, Dirk Hose, Carsten Bokemeyer, Marc-Steffen Raab
Publikováno v:
Leukemia
Multiple myeloma is a mostly incurable malignancy characterized by the expansion of a malignant plasma cell (PC) clone in the human bone marrow (BM). Myeloma cells closely interact with the BM stroma, which secretes soluble factors that foster myelom
Autor:
Mark Wroblewski, Carsten Bokemeyer, Peter Carmeliet, Jasmin Wellbrock, Stefanie Sawall, Robert Erdmann, Victoria Witzke, Melanie Janning, Alexander Schultze, Isabel Ben-Batalla, Denis M. Schewe, Christian Hagel, Miguel Cubas-Cordova, Jonas S. Waizenegger, Sonja Loges, Kristoffer Riecken, Mascha Binder, Arnold Ganser, Walter Fiedler, Klaus Pantel, Jürgen Krauter, James B. Lorens, Michael Heuser, Boris Fehse
Publikováno v:
Blood
Acute myeloid leukemia (AML) represents a clonal disease of hematopoietic progenitors characterized by acquired heterogenous genetic changes that alter normal mechanisms of proliferation, self-renewal, and differentiation.(1) Although 40% to 45% of p
Autor:
Jonas S. Waizenegger, Julian Pardo Jimeno, Florian Udonta, Miguel Cubas Cordova, Stefanie Sawall, Sonja Loges, Mark Wroblewski, Isabel Ben Batalla, Klaus Pantel, Victoria Gensch, Carsten Bokemeyer, Raimund Bauer
Publikováno v:
Cancer Research. 76:3253-3253
Significance: Targeted therapies have revolutionized the treatment of cancer. However, efficacy of anti-angiogenic therapies is limited due to significant resistance. Recent studies showed that the tumor microenvironment is involved in resistance tow
Autor:
Christian Grossardt, Christof von Kalle, Vincent H. J. Leonard, Guy Ungerechts, Karim Zaoui, Tanner Miest, Stefanie Sawall, Sascha Bossow, Mathias F. Leber, Marie Frenzke, Roberto Cattaneo
Publikováno v:
Molecular therapy : the journal of the American Society of Gene Therapy. 19(6)
Oncolytic measles viruses (MV) derived from the live attenuated vaccine strain have been engineered for increased tumor-cell specificity, and are currently under investigation in clinical trials including a phase I study for glioblastoma multiforme (
Autor:
Mascha Binder, Nicolaus Kroeger, Isabel Ben-Batalla, Andreas Hochhaus, Gunhild von Amsberg, David Micklem, Tim H. Brümmendorf, Heather Morrison, Victoria Gensch, Philippe Schafhausen, Alexander Schultze, Steffen Koschmieder, Sonja Loges, Miguel Cubas-Cordova, Tobias Hadlich, Melanie Janning, Carsten Bokemeyer, Richard E. Clark, James B. Lorens, Peter Vandenberghe, Mark Wroblewski, Robert Erdmann, Heather G. Jørgensen, Jennifer Cassells, Elaine K. Allan, Tessa L. Holyoake, Klaus Pantel, Nils Kruse, Peter Carmeliet, Stefanie Sawall, Leena Mukherjee
Publikováno v:
Blood. 124:4512-4512
BCR-ABL1 inhibitors have revolutionized the treatment of CML patients. However several drawbacks remain, including clinical resistance of T315I-mutated CML. Further, the clinical success of ponatinib, a selective inhibitor of T315I-mutated BCR-ABL1 i
Autor:
Stefanie Sawall, Miguel Cubas-Cordova, Victoria Gensch, Florian Udonta, Mark Wroblewski, Klaus Pantel, Sonja Loges, Isabel Ben Batalla, Carsten Bokemeyer
Publikováno v:
Cancer Research. 74:1161-1161
Efficacy of anti-angiogenic drugs is hampered by hypoxia-induced resistance. Because cyclooxygenase-2 (Cox-2) is upregulated in hypoxic conditions we analyzed mRNA expression levels of cyclooxygenase-1 (Cox-1) and Cox-2 in GFP+ FACS-sorted tumor cell